{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:54:14Z","timestamp":1784318054676,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["315690"],"award-info":[{"award-number":["315690"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["308009"],"award-info":[{"award-number":["308009"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004325","name":"Signe ja Ane Gyllenbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Incidence of gestational diabetes (GDM) has increased rapidly. It poses significant risks for both mother and fetus affecting also negatively their longer-term metabolic heath. We asked whether early pregnancy maternal hemoglobin (Hb) levels, indicative for tissue oxygenation, would affect mother\u2019s metabolic health and fetal outcome. We assessed in FinnGeDi, a Finnish multicenter case\u2013control study for GDM (n\u2009=\u20091828), association of maternal 1st trimester Hb levels with metabolic parameters and perinatal outcome. Our data show that mothers with GDM had higher Hb levels compared to controls (mean difference 1.746\u00a0g\/L). Hb levels associated positively with pre-pregnancy body mass index (BMI), fasting glucose levels and glucose levels in a glucose tolerance test and systolic and diastolic blood pressure (bp) levels. When assessed in quartiles the highest Hb quartile had more chronic and gestational hypertension and the most adverse outcome of the metabolic parameters, dose-dependency seen in bp, BMI and glucose levels. In a multivariable regression analysis Hb levels remained an independently associated parameter for GDM after adjusting for key covariates (OR 1.019, 95% CI [1.007; 1.031]). In conclusion, higher maternal Hb levels within the normal variation are an independent risk factor for GDM in this population but have little effect on perinatal outcome.<\/jats:p>","DOI":"10.1038\/s41598-022-05801-y","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T11:18:28Z","timestamp":1643627908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Higher hemoglobin levels are an independent risk factor for gestational diabetes"],"prefix":"10.1038","volume":"12","author":[{"given":"Niina","family":"Sissala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Mustaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Kajantie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"V\u00e4\u00e4r\u00e4sm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peppi","family":"Koivunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"5801_CR1","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s00125-016-3985-5","volume":"59","author":"P Damm","year":"2016","unstructured":"Damm, P. et al. Gestational diabetes mellitus and long-term consequences for mother and offspring: A view from Denmark. Diabetologia 59, 1396\u20131399 (2016).","journal-title":"Diabetologia"},{"key":"5801_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-019-0098-8","volume":"5","author":"HD McIntyre","year":"2019","unstructured":"McIntyre, H. D. et al. Gestational diabetes mellitus. Nat. Rev. Dis. Primers 5, 47\u201348 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"5801_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ecl.2019.05.001","volume":"48","author":"ED Szmuilowicz","year":"2019","unstructured":"Szmuilowicz, E. D., Josefson, J. L. & Metzger, B. E. Gestational diabetes mellitus. Endocrinol. Metab. Clin. North Am. 48, 479\u2013493 (2019).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"5801_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","volume":"16","author":"Y Zhu","year":"2016","unstructured":"Zhu, Y. & Zhang, C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: A global perspective. Curr. Diabetes Rep. 16, 7 (2016).","journal-title":"Curr. Diabetes Rep."},{"key":"5801_CR5","volume-title":"Gestational Diabetes","author":"A Tiitinen","year":"2021","unstructured":"Tiitinen, A. Gestational Diabetes (Finnish Medical Society Duodecim, 2021)."},{"key":"5801_CR6","unstructured":"The Finnish Institute for Health (THL). Perinatal statistics\u2014parturients, deliveries and newborns 2019. Official Statistics of Finland, Perinaltal statistics, Vol. 48\/2020. https:\/\/www.julkari.fi\/handle\/10024\/140702 (2020)."},{"key":"5801_CR7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00125-016-3976-6","volume":"59","author":"M V\u00e4\u00e4r\u00e4sm\u00e4ki","year":"2016","unstructured":"V\u00e4\u00e4r\u00e4sm\u00e4ki, M. Is it worth treating gestational diabetes: If so, when and how?. Diabetologia 59, 1391\u20131395 (2016).","journal-title":"Diabetologia"},{"key":"5801_CR8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00125-016-3979-3","volume":"59","author":"C Zhang","year":"2016","unstructured":"Zhang, C., Rawal, S. & Chong, Y. S. Risk factors for gestational diabetes: Is prevention possible?. Diabetologia 59, 1385\u20131390 (2016).","journal-title":"Diabetologia"},{"key":"5801_CR9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature11677","volume":"492","author":"P van der Harst","year":"2012","unstructured":"van der Harst, P. et al. Seventy-five genetic loci influencing the human red blood cell. Nature 492, 369\u2013375 (2012).","journal-title":"Nature"},{"key":"5801_CR10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3324\/haematol.13692","volume":"93","author":"KV Patel","year":"2008","unstructured":"Patel, K. V. Variability and heritability of hemoglobin concentration: An opportunity to improve understanding of anemia in older adults. Haematologica 93, 1281\u20131283 (2008).","journal-title":"Haematologica"},{"key":"5801_CR11","unstructured":"World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. https:\/\/apps.who.int\/iris\/handle\/10665\/85839 (2011)."},{"key":"5801_CR12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/HYPERTENSIONAHA.112.193565","volume":"60","author":"F Atsma","year":"2012","unstructured":"Atsma, F. et al. Hemoglobin level is positively associated with blood pressure in a large cohort of healthy individuals. Hypertension 60, 936\u2013941 (2012).","journal-title":"Hypertension"},{"key":"5801_CR13","doi-asserted-by":"crossref","first-page":"eabi4822","DOI":"10.1126\/sciadv.abi4822","volume":"7","author":"J Auvinen","year":"2021","unstructured":"Auvinen, J. et al. Systematic evaluation of the association between hemoglobin levels and metabolic profile implicates beneficial effects of hypoxia. Sci. Adv. 7, eabi4822 (2021).","journal-title":"Sci. Adv."},{"key":"5801_CR14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12020-015-0587-9","volume":"50","author":"Y Hashimoto","year":"2015","unstructured":"Hashimoto, Y. et al. Hemoglobin concentration and incident metabolic syndrome: A population-based large-scale cohort study. Endocrine 50, 390\u2013396 (2015).","journal-title":"Endocrine"},{"key":"5801_CR15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1479-828X.2010.01220.x","volume":"50","author":"C Abeysena","year":"2010","unstructured":"Abeysena, C., Jayawardana, P. & de A Seneviratne, R. Maternal haemoglobin level at booking visit and its effect on adverse pregnancy outcome. Aust. N. Z. J. Obstet. Gynaecol. 50, 423\u2013427 (2010).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"5801_CR16","first-page":"807","volume":"99","author":"TT Lao","year":"2002","unstructured":"Lao, T. T., Chan, L. Y., Tam, K. F. & Ho, L. F. Maternal hemoglobin and risk of gestational diabetes mellitus in Chinese women. Obstet. Gynecol. 99, 807\u2013812 (2002).","journal-title":"Obstet. Gynecol."},{"key":"5801_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/JPM.2008.018","volume":"36","author":"C Phaloprakarn","year":"2008","unstructured":"Phaloprakarn, C. & Tangjitgamol, S. Impact of high maternal hemoglobin at first antenatal visit on pregnancy outcomes: A cohort study. J. Perinat. Med. 36, 115\u2013119 (2008).","journal-title":"J. Perinat. Med."},{"key":"5801_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0020-7292(03)00341-2","volume":"84","author":"E Tarim","year":"2004","unstructured":"Tarim, E., Kilicdag, E., Bagis, T. & Ergin, T. High maternal hemoglobin and ferritin values as risk factors for gestational diabetes. Int. J. Gynaecol. Obstet. 84, 259\u2013261 (2004).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"5801_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12884-018-1800-7","volume":"18","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Hemoglobin levels during the first trimester of pregnancy are associated with the risk of gestational diabetes mellitus, pre-eclampsia and preterm birth in Chinese women: A retrospective study. BMC Pregnancy Childbirth 18, 263\u2013267 (2018).","journal-title":"BMC Pregnancy Childbirth"},{"key":"5801_CR20","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/ije\/dyaa039","volume":"49","author":"E Keikkala","year":"2020","unstructured":"Keikkala, E. et al. Cohort profile: The Finnish Gestational Diabetes (FinnGeDi) study. Int. J. Epidemiol. 49, 762\u2013763 (2020).","journal-title":"Int. J. Epidemiol."},{"key":"5801_CR21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1530\/EC-18-0076","volume":"7","author":"S Mustaniemi","year":"2018","unstructured":"Mustaniemi, S. et al. Polycystic ovary syndrome and risk factors for gestational diabetes. Endocr. Connect. 7, 859\u2013869 (2018).","journal-title":"Endocr. Connect."},{"key":"5801_CR22","volume-title":"Current Care Guideline. Gestational Diabetes","author":"Working Group Established by the Finnish Medical Society Duodecim, the M. A. B. of the F. D. A. and the F. G. Association","year":"2008","unstructured":"Working Group Established by the Finnish Medical Society Duodecim, the M. A. B. of the F. D. A. and the F. G. Association. Current Care Guideline. Gestational Diabetes (Finnish Medical Society Duodecim, 2008)."},{"key":"5801_CR23","first-page":"5147","volume":"58","author":"V Kairisto","year":"2003","unstructured":"Kairisto, V. et al. New Finnish reference limits for basic blood count. Suom. Laakaril. 58, 5147\u20135153 (2003).","journal-title":"Suom. Laakaril."},{"key":"5801_CR24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/07853890.2013.803739","volume":"45","author":"U Sankilampi","year":"2013","unstructured":"Sankilampi, U., Hannila, M. L., Saari, A., Gissler, M. & Dunkel, L. New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann. Med. 45, 446\u2013454 (2013).","journal-title":"Ann. Med."},{"key":"5801_CR25","volume":"16","author":"M Li","year":"2021","unstructured":"Li, M., Hu, M., Yue, Z., Zhang, Y. & Yang, H. The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus. PLoS\u00a0One 16, e0257391 (2021).","journal-title":"PLoS\u00a0One"},{"key":"5801_CR26","volume":"171","author":"HY Kim","year":"2021","unstructured":"Kim, H. Y. et al. Prepregnancy hemoglobin levels and gestational diabetes mellitus in pregnancy. Diabetes Res. Clin. Pract. 171, 108608 (2021).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"5801_CR27","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0164","author":"X Chen","year":"2006","unstructured":"Chen, X., Scholl, T. O. & Stein, T. P. Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women. The Camden study. Diabetes Care https:\/\/doi.org\/10.2337\/dc06-0164 (2006).","journal-title":"Diabetes Care"},{"key":"5801_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12011-013-9703-y","volume":"154","author":"S Behboudi-Gandevani","year":"2013","unstructured":"Behboudi-Gandevani, S. et al. The relationship between maternal serum iron and zinc levels and their nutritional intakes in early pregnancy with gestational diabetes. Biol. Trace Elem. Res. 154, 7\u201313 (2013).","journal-title":"Biol. Trace Elem. Res."},{"key":"5801_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.29252\/ijrm.15.3.155","volume":"15","author":"S Soheilykhah","year":"2017","unstructured":"Soheilykhah, S., Mojibian, M. & Moghadam, M. J. Serum ferritin concentration in early pregnancy and risk of subsequent development of gestational diabetes: A prospective study. Int. J. Reprod. Biomed. 15, 155 (2017).","journal-title":"Int. J. Reprod. Biomed."},{"key":"5801_CR30","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/diacare.27.3.650","volume":"27","author":"TT Lao","year":"2004","unstructured":"Lao, T. T. & Ho, L. F. Impact of iron deficiency anemia on prevalence of gestational diabetes mellitus. Diabetes Care 27, 650\u2013656 (2004).","journal-title":"Diabetes Care"},{"key":"5801_CR31","doi-asserted-by":"crossref","first-page":"nyas.14112","DOI":"10.1111\/nyas.14112","volume":"1450","author":"J Jung","year":"2019","unstructured":"Jung, J. et al. Effects of hemoglobin levels during pregnancy on adverse maternal and infant outcomes: A systematic review and meta-analysis. Ann. N. Y. Acad. Sci. 1450, nyas.14112 (2019).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"5801_CR32","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2337\/diabetes.51.8.2348","volume":"51","author":"JM Fern\u00e1ndez-Real","year":"2002","unstructured":"Fern\u00e1ndez-Real, J. M., L\u00f3pez-Bermejo, A. & Ricart, W. Cross-talk between iron metabolism and diabetes. Diabetes 51, 2348\u20132354 (2002).","journal-title":"Diabetes"},{"key":"5801_CR33","doi-asserted-by":"crossref","first-page":"13583","DOI":"10.1038\/s41598-018-31908-2","volume":"8","author":"J M\u00e4\u00e4tt\u00e4","year":"2018","unstructured":"M\u00e4\u00e4tt\u00e4, J. et al. Hypoxia causes reductions in birth weight by altering maternal glucose and lipid metabolism. Sci. Rep. 8, 13583 (2018).","journal-title":"Sci. Rep."},{"key":"5801_CR34","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.2337\/db14-0472","volume":"63","author":"L Rahtu-Korpela","year":"2014","unstructured":"Rahtu-Korpela, L. et al. HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction. Diabetes 63, 3324\u20133333 (2014).","journal-title":"Diabetes"},{"key":"5801_CR35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00000542-196507000-00004","volume":"26","author":"JA Pritchard","year":"1965","unstructured":"Pritchard, J. A. Changes in the blood volume during pregnancy and delivery. Anesthesiology 26, 393\u2013399 (1965).","journal-title":"Anesthesiology"},{"key":"5801_CR36","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0140-6736(86)91269-9","volume":"1","author":"JF Murphy","year":"1986","unstructured":"Murphy, J. F., O\u2019Riordan, J., Newcombe, R. G., Coles, E. C. & Pearson, J. F. Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet (London, England) 1, 992\u2013995 (1986).","journal-title":"Lancet (London, England)"},{"key":"5801_CR37","volume-title":"\u00c4itiysneuvolaopas\u2014Suosituksia \u00e4itiysneuvolatoimintaan (Recomendations for Maternal Health Center)","author":"R Klemetti","year":"2013","unstructured":"Klemetti, R. & Hakulinen-Viitanen, T. \u00c4itiysneuvolaopas\u2014Suosituksia \u00e4itiysneuvolatoimintaan (Recomendations for Maternal Health Center) (The National Institute for Health and Welfare (THL), 2013)."},{"key":"5801_CR38","doi-asserted-by":"crossref","first-page":"19936","DOI":"10.1038\/s41598-021-99217-9","volume":"11","author":"J Tapio","year":"2021","unstructured":"Tapio, J., V\u00e4h\u00e4nikkil\u00e4, H., Kes\u00e4niemi, Y. A., Ukkola, O. & Koivunen, P. Higher hemoglobin levels are an independent risk factor for adverse metabolism and higher mortality in a 20-year follow-up. Sci. Rep. 11, 19936 (2021).","journal-title":"Sci. Rep."},{"key":"5801_CR39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00016348609158396","volume":"65","author":"A Huisman","year":"1986","unstructured":"Huisman, A. & Aarnoudse, J. G. Increased 2nd trimester hemoglobin concentration in pregnancies later complicated by hypertension and growth retardation. Early evidence of a reduced plasma volume. Acta Obst. Gynecol. Scand. 65, 605\u2013608 (1986).","journal-title":"Acta Obst. Gynecol. Scand."},{"key":"5801_CR40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2105\/AJPH.87.6.1003","volume":"87","author":"GM Jensen","year":"1997","unstructured":"Jensen, G. M. & Moore, L. G. The effect of high altitude and other risk factors on birthweight: Independent or interactive effects?. Am. J. Public Health 87, 1003\u20131007 (1997).","journal-title":"Am. J. Public Health"},{"key":"5801_CR41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111838","volume":"9","author":"I Flamme","year":"2014","unstructured":"Flamme, I. et al. Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85\u20133934 (Molidustat) stimulates erythropoietin production without hypertensive effects. PLoS ONE 9, e111838 (2014).","journal-title":"PLoS ONE"},{"key":"5801_CR42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneph.2015.193","volume":"12","author":"PH Maxwell","year":"2016","unstructured":"Maxwell, P. H. & Eckardt, K.-U. HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond. Nat. Rev. Nephrol. 12, 157\u2013168 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"5801_CR43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1358863X14557151","volume":"19","author":"E Olson","year":"2014","unstructured":"Olson, E. et al. Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease. Vasc. Med. 19, 473\u2013482 (2014).","journal-title":"Vasc. Med."},{"key":"5801_CR44","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2215\/CJN.06890615","volume":"11","author":"R Provenzano","year":"2016","unstructured":"Provenzano, R. et al. Oral hypoxia-inducible factor prolyl hydroxylase inhibitor Roxadustat (FG-4592) for the treatment of anemia in patients with CKD. Clin. J. Am. Soc. Nephrol. 11, 982\u2013991 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05801-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T21:24:32Z","timestamp":1669325072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05801-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5801"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05801-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"16 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1686"}}